中国科技核心期刊
CN:31-1600/Q
ISSN:1004-0374
“健康与疾病的免疫”国际学术研讨会通知      关于有网站冒充本刊网站的声明
《生命科学》 2015, 27(2): 135-142
T-box转录因子Brachyury在肿瘤相关研究中的进展
刘 飞,唐旭东*
(广东医学院生物化学与分子生物学研究所,湛江 524023)
摘 要:Brachyury 是T-box 转录因子家族的重要成员,与肿瘤发展密切相关,在肿瘤上皮- 间质转化(epithelial-mesenchymal transition, EMT) 中发挥重要作用,可能成为肿瘤免疫治疗的潜在靶点。从Brachyury与肿瘤转移、分期、预后的关系,对肿瘤EMT 的诱导调节,对肿瘤传统治疗的抵抗及靶向Brachyury 的肿瘤免疫治疗等方面进行了综述,并展望了Brachyury 未来的研究方向和临床应用前景。
 
Research progress of T-box transcription factor Brachyury in tumor
LIU Fei, TANG Xu-Dong*
(Institute of Biochemistry and Molecular Biology, Guangdong Medical College, Zhanjiang 524023, China)
Abstract: Brachyury is a founding member of T-box transcription factor family. Recently, accumulating evidence demonstrated that Brachyury is closely related to tumor progression, and plays a key role in the process of epithelial-mesenchymal transition (EMT), suggesting Brachyury may be a potential target for T cellmediated immunotherapy of cancer. This review summarized the relationship between Brachyury and tumor metastasis, staging, and prognosis, the induction and regulation of EMT mediated by Brachyury, and the role of Brachyury in the resistance to traditional therapy of cancer and cancer immunotherapy targeting Brachyury. It also gived fresh perspectives on further investigation and clinical application of Brachyury.
 
首页 | 刊物简介 | 编委会 | 投稿须知 | 广告业务 | 过刊浏览 | 联系我们
中国科学院上海生命科学信息中心《生命科学》编辑部
Copyright © 2012-2015 《生命科学》编辑部 All Rights Reserved.
沪ICP备05033115号-30
您是第2872160 位访问者,欢迎!